| abstract |
Compositions containing a phenylquinoline derivative compound having peroxisome proliferator-activated receptor a (PPARĪ±) agonistic activity, and methods of their use in enhancing PPARĪ± activity in retinal cells, and in treating ocular disorders or conditions, such as but not limited to retinal inflammation, retinal neovascularization, retinal vascular leakage, retinopathy of prematurity, diabetic retinopathy, age-related macular degeneration, and diabetic macular edema are disclosed. |